Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Efficacy of SB-206284A in animal models of cerebral ischemia

June 26, 1997

MS&D prepares potent and selective 5-HT1D agonists

June 26, 1997

Selective dopamine D3 receptor ligands from Novo Nordisk

June 26, 1997

P&U prepares inhibitors of kynurenine 3-hydroxylase for neurodegenerative diseases

June 26, 1997

Novel melatonergic agents described by Bristol-Myers Squibb

June 26, 1997

Naratriptan highlighted at headache congress; introduced in U.K.

June 26, 1997

RTP Pharma receives U.S. patent for new formulation of propofol

June 25, 1997

Single efficacy trial for transdermal buspirone required by FDA

June 25, 1997

IND approved for multiple sclerosis drug from TCAR program

June 25, 1997

Preclinical and preliminary clinical results reported for alniditan

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...